iifl-logo

Indoco Remedies Ltd Annually Results

232.48
(-2.67%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,788.22

1,640.05

1,503.73

1,218.61

1,079.98

Excise Duty

0

0

0

0

0

Net Sales

1,788.22

1,640.05

1,503.73

1,218.61

1,079.98

Other Operating Income

29.07

28.56

37.02

22.92

26.61

Other Income

21.38

2.34

2.33

3.12

2.44

Total Income

1,838.67

1,670.95

1,543.08

1,244.65

1,109.03

Total Expenditure

1,572.98

1,382.51

1,213.41

1,017.26

983.38

PBIDT

265.69

288.44

329.67

227.39

125.65

Interest

38.02

25.03

14.14

22.26

26.25

PBDT

227.67

263.41

315.53

205.13

99.4

Depreciation

91.87

70.61

78.96

73.13

70.82

Minority Interest Before NP

0

0

0

0

0

Tax

33.17

55.51

89.12

38.57

0

Deferred Tax

5.62

-4.96

-7.35

0.38

4.46

Reported Profit After Tax

97.01

142.25

154.8

93.05

24.12

Minority Interest After NP

-1.46

0

0

0

0

Net Profit after Minority Interest

98.47

142.25

154.8

93.05

24.12

Extra-ordinary Items

8.24

0

0

0

0

Adjusted Profit After Extra-ordinary item

90.23

142.25

154.8

93.05

24.12

EPS (Unit Curr.)

10.53

15.44

16.8

10.1

2.62

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

75

112.5

112.5

75

15

Equity

18.44

18.43

18.43

18.43

18.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.85

17.58

21.92

18.65

11.63

PBDTM(%)

12.73

16.06

20.98

16.83

9.2

PATM(%)

5.42

8.67

10.29

7.63

2.23

Indoco Remedies: Related NEWS

USFDA Inspects Indoco’s AnaCipher Unit, Issues Form 483
11 Mar 2025|01:48 PM

Indoco Remedies stated that it will respond to the Form 483 observations within the prescribed timeline.

Read More
Top Stocks for Today - 11th March 2025
11 Mar 2025|07:11 AM

Here are some of the stocks that may see significant price movement today: IndusInd Bank, Hindustan Zinc, Thermax, etc.

Read More
Indoco Partners with Clarity Pharma to Launch 20 Affordable Drugs in UK
4 Dec 2024|01:37 PM

Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.